Category:Cancer treatments
From WikiMD's Food, Medicine & Wellness Encyclopedia
 | Pages in this category should be moved to subcategories where applicable. This category may require frequent maintenance to avoid becoming too large. It should directly contain very few, if any, pages and should mainly contain subcategories. |
Subcategories
This category has the following 2 subcategories, out of 2 total.
Pages in category "Cancer treatments"
The following 200 pages are in this category, out of 472 total.
(previous page) (next page)A
- Abituzumab
- ABT-510
- Active immunotherapy
- ADE (chemotherapy)
- ADH-1
- Adjuvant therapy
- Adjuvant chemotherapy
- Adoptive immunotherapy
- ADXS11-001
- Aldesleukin
- ALK inhibitor
- Alkylating antineoplastic agents
- Alpelisib
- Alternating electric field therapy
- Altumomab pentetate
- AMG 319
- Andrographolide
- ANG1005
- Annamycin
- Anti-idiotypic vaccine
- Anti-VEGF
- Antiangiogenesis
- Antibody-drug conjugates
- Antibody–drug conjugate
- Antihormone therapy
- Template:Antineoplastic-agents-stub
- Antineoplastics
- Apatinib
- Aromatase Inhibitor
- Artificial fever
- Asparaginase erwinia chrysanthemi
- Atrasentan
- Auger therapy
- Autologous immune enhancement therapy
- Autologous tumor cell
- Avadomide
- Avapritinib
- Avicine
- Axicabtagene ciloleucel
B
C
- C-1027
- Caffeic acid phenethyl ester
- Camidanlumab tesirine
- Cancer Chemotherapy and Pharmacology
- Cancer drugs
- Cancer therapy
- Cantuzumab
- Capmatinib
- Capsaicin
- CAR T cell
- Carmustine
- Carmustine implant
- Catumaxomab
- Cerdulatinib
- Chemotherapy
- Chemotherapy drug
- Chimeric antigen receptor T cell
- Cisplatin
- Citatuzumab
- Clostridium novyi-NT
- Cofetuzumab pelidotin
- Coley's toxins
- Combinatorial ablation and immunotherapy
- Combined photothermal and photodynamic therapy
- Combretastatin A-4 Phosphate
- Conization
- Continuous hyperthermic peritoneal perfusion
- Cryoimmunotherapy
- Cryosurgery
- Custirsen
- Cyberknife (device)
- Cytarabine
- Cytokine-induced Killer Cell
- Cytostatic
D
- Dabrafenib
- Dacarbazine
- Dactolisib
- Dalantercept
- Dalotuzumab
- DAT (chemotherapy)
- Debulking
- Defactinib
- Demcizumab
- Dendritic cell-based cancer vaccine
- Detumomab
- Devimistat
- Dinutuximab beta
- Discovery and development of tubulin inhibitors
- Donor lymphocyte infusion
- Dose-dense chemotherapy
- Duligotumab
- Dusigitumab
E
F
G
H
- Heavy ion therapy
- Hepatic arterial infusion
- Hereditary condition
- HIPEC
- History of cancer chemotherapy
- Hormonal antineoplastic drugs
- Hormonal therapy
- Hormonal therapy (oncology)
- HPPH
- HU-336
- Hyperfractionated radiation therapy
- Hyperthermia therapy
- Hyperthermic intraperitoneal chemotherapy
- Hyperthermic perfusion
- Hypofractionation
I
- Iberdomide
- Idecabtagene vicleucel
- IGRT
- Image-guided radiation therapy
- Imatinib mesylate
- IMEP (chemotherapy)
- Imexon
- IMM-101
- IMMU-110
- Immunoconjugates
- Immunotoxin
- Immunotoxins
- IMRT
- Inavolisib
- Infigratinib
- Iniparib
- Insulin potentiation therapy
- Interferon alpha
- Interleukin-2
- Internal radiation
- Intraoperative electron radiation therapy
- Intraoperative radiation therapy
- Intraperitoneal
- Intrathecal chemotherapy
- Iodine (125I) minretumomab
- Iodine i 131 tositumomab
- IPI-549
- Irreversible electroporation
- Isolated limb perfusion
- Isolated organ perfusion technique
- Isosulfan blue
- Ivarmacitinib
